Plus, news about Atara Biotherapeutics, Immutep, bluebird bio, OSE Immunotherapeutics, Mersana Therapeutics, Innovent, Biomea Fusion and Trailhead Biosystems:
Eli Lilly does another ALS deal: The pharma is licensing an IND-ready antibody from Alchemab Therapeutics. Lilly ...
↧